Tuesday, May 18, 2021 |
Partly Cloudy

CEO at troubled vaccine plant received 51 percent compensation boost in 2020

April 12, 2021

Emergent BioSolutions, the troubled manufacturer at the heart of Johnson & Johnson’s coronavirus vaccine production problems, gave its chief executive officer a 51 percent increase in total compensation in 2020, to $5.6 million, according to a public filing Friday. The annual proxy disclosure by the publicly traded company said CEO Robert Kramer received $893,000 in salary, a $1.2 million bonus, $2.1 million in stock awards, and $1.4 million in stock options.

Article Source: Washington Post

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.